Vometa
Cambodia • Dexa Medica
Indication
Symptomatic treatment of dyspeptic syndrome that may be associated with delayed gastric emptying, gastroesophageal reflux and esophagitis
- Epigastric sense of fullness, feeling of fullness abdominal distension
- Bloating, burping
- Nausea and vomiting
- Heartburn with or without regurgitation of stomach contents to mouth
Nausea, vomiting, burping due to various causes
- Gastrointestinal intolerance due to anticancer chemotherapy, digitalis, levodopa and others including radiotherapy
- Abdominal organs, gastrointestinal hepatobiliary, peritoneal and renal pathology
- Vometa is not recommended for pediatrics unless to prevent nausea and vomiting associated with chemotherapy or cancer radiotherapy
Composition
Domperidone 5 mg
Package
Dosage Forms
SuspensionATC Classification
Warning
Dosage
0 to 18 Years Old
Children (nausea and vomiting related to chemotherapy and radiotherapy):
2.5 mg per 10 kg body weight, 3-4 times daily before meals and before bedtime.
Use in infants/pediatric:
The dose should be determined accurately and followed strictly in neonates, infants and children.
18 Years Old and Above
The dose should be the lowest effective dose for the individual situation (typically 30 mg/day) and the dose may be increased, to a maximum daily oral dose of 40 mg/day.
Chronic dyspepsia:
10 mg, 3 times daily, 15-30 minutes before meals and before bedtime.
Nausea and vomiting:
10 mg, 3-4 times daily before meals and before bedtime.
Use in Patient with Renal Impairment
Since very little unchanged drug is excreted via the kidneys, dose modification in patients with renal insufficiency is not needed. Therefore, on repeated administration, the dosing frequency of domperidone should be reduced to once or twice daily depending on the severity of the impairment, and the dose may need to be reduced. Such patients on prolonged therapy should be reviewed regularly.